40
Participants
Start Date
April 2, 2021
Primary Completion Date
July 1, 2025
Study Completion Date
December 1, 2025
Institutional standard intravenous immune globulin treatment
No treatments will be prospectively assigned. Subjects will receive their standard intravenous immune globulin doses. We will measure body composition and identify the relationship between body composition and intravenous immune globulin disposition.
RECRUITING
Robert Wood Johnson University Hospital Somerset, Somerville
Rutgers, The State University of New Jersey
OTHER